Development and Content Validity of the Clinical Needs Assessment for Myalgic Encephalomyelitis (CNAME)
Health Expectations · 2026-10 · 29 (5)
DOI: 10.1111/hex.70854 ↗At a glance
Validierungsstudie in Health Expectations, published online on 2026-08-26. Written by Sarah F Tyson and 1 co-authors. Institution: School of Health Science, University of Manchester, UK. Major MEDLINE topics: Needs Assessment, Fatigue Syndrome, Chronic. Cited 1 times so far (Crossref); 30 references. The full text is freely available (open access, CC BY 4.0). Funded by: ME Association, UK.
Abstract (original language)
Background
To co‐produce the Clinical Needs Assessment for Myalgic Encephalomyelitis (CNAME) with patients and clinicians, and to assess its content validity.
Methods
Guided by the COSMIN guidelines, a draft CNAME was devised from relevant literature and lived experience. It was revised following piloting and cognitive interviews with the advisory groups and then completed online by people with ME. Content and face validity were assessed via deductive framework analysis of participants’ feedback. Construct validity (in terms of relevance, duplication and comprehensibility) was assessed using frequencies, cross‐tabulations and response rates, respectively. As the CNAME produces dichotomous (yes/no or not relevant) data, which are not summated and are not intended for repeated use, further psychometric analyses are not possible or relevant.
Results
Four hundred people with ME participated. Comprehensibility was excellent (> 97.5% item completion rate). There were no floor effects, but several items had a ceiling effect and were removed. Eight items demonstrated duplication and were combined. Participant feedback was positive, confirming that the CNAME addressed the issues that were important and relevant to them and was easy to complete.
Conclusions
The Clinical Needs Assessment for ME is a valid, feasible and acceptable measure of people with ME/CFS’ clinical needs. Patient and Public Contribution Development of the CNAME was a patient‐led project (both the authors live with ME/CFS) and it was co‐produced by people with ME/CFS and clinicians working in NHS specialist ME/CFS services. People with ME/CFS and clinicians were involved in all stages of the study—conceptualisation, design, conduct, analysis, interpretation and dissemination.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- School of Health Science, University of Manchester, UK.
- ME Association, Buckingham, Buckinghamshire, UK.
ORCID profiles: Sarah F Tyson
Funding
- ME Association, UK
Cite
APA
Tyson, S. F., & Fleming, R. (2026). Development and Content Validity of the Clinical Needs Assessment for Myalgic Encephalomyelitis (CNAME). Health Expectations, 29(5). https://doi.org/10.1111/hex.70854
Vancouver
Tyson SF, Fleming R. Development and Content Validity of the Clinical Needs Assessment for Myalgic Encephalomyelitis (CNAME). Health Expectations. 2026;29(5). doi:10.1111/hex.70854
BibTeX
@article{Tyson2026,
author = {Tyson, Sarah F and Fleming, Russell},
title = {Development and Content Validity of the Clinical Needs Assessment for Myalgic Encephalomyelitis (CNAME)},
journal = {Health Expectations},
year = {2026},
volume = {29},
number = {5},
doi = {10.1111/hex.70854}
}
EUVIMED